Sigma-Aldrich Acquires Research Organics to Strengthen Portfolio of Pharmaceutical-Grade Raw Materials

Sigma-Aldrich says it has acquired all outstanding shares of Research Organics (Cleveland, OH), to expand the company’s buffer production capacity and to increase its portfolio of pharma grade raw materials for the biopharmaceutical and diagnostic markets. Financial terms of the purchase were not disclosed. Research Organics is a leading supplier of high purity biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences and biotechnology and will transition into Sigma-Aldrich Fine Chemicals...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers